# Entera Bio (ENTX) — Earnings

ENTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/entx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.06 |
| EPS estimate | −$0.11 |
| EPS surprise | +45.45% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 8, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1638097/000117891325002702/zk2533523.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 8, 2025 | −$0.11 | −$0.06 | 45.45% | — | — |
| Q1 2025 | May 9, 2025 | −$0.07 | −$0.06 | 14.29% | — | — |
| Q4 2024 | Mar 28, 2025 | −$0.08 | −$0.06 | 25.00% | $40,000.00 | $40,000.00 |
| Q3 2024 | Nov 8, 2024 | −$0.05 | −$0.08 | -60.00% | $40,000.00 | $42,000.00 |
| Q2 2024 | Aug 9, 2024 | −$0.06 | −$0.06 | 0.00% | — | $57,000.00 |
| Q1 2024 | May 10, 2024 | −$0.06 | −$0.05 | 16.67% | — | — |
| Q4 2023 | Mar 8, 2024 | −$0.08 | −$0.06 | 25.00% | — | — |
| Q3 2023 | Nov 14, 2023 | −$0.09 | −$0.08 | 11.11% | — | — |
| Q2 2023 | Aug 11, 2023 | −$0.07 | −$0.08 | -14.29% | — | $14,000.00 |
| Q1 2023 | May 5, 2023 | −$0.12 | −$0.08 | 33.33% | $100,000.00 | $13,000.00 |
| Q4 2022 | Mar 31, 2023 | −$0.12 | −$0.10 | 13.04% | $90,000.00 | $14,000.00 |
| Q3 2022 | Nov 10, 2022 | −$0.14 | −$0.11 | 18.52% | $70,000.00 | $8,000.00 |
| Q2 2022 | Aug 11, 2022 | −$0.16 | −$0.11 | 31.25% | $100,000.00 | $51,000.00 |
| Q1 2022 | May 12, 2022 | −$0.18 | −$0.13 | 26.76% | $178,500.00 | $68,000.00 |
| Q4 2021 | Mar 8, 2022 | −$0.23 | $0.21 | 190.01% | $127,000.00 | $161,000.00 |
| Q3 2021 | Nov 10, 2021 | −$0.12 | −$0.09 | 21.74% | $120,000.00 | $140,000.00 |
| Q2 2021 | Aug 16, 2021 | −$0.12 | −$0.21 | -70.32% | $173,000.00 | $109,000.00 |
| Q1 2021 | May 20, 2021 | −$0.12 | −$0.43 | -258.33% | $91,000.00 | $157,000.00 |
| Q4 2020 | Mar 18, 2021 | −$0.14 | −$0.12 | 14.29% | — | $200,000.00 |
| Q3 2020 | Nov 19, 2020 | −$0.20 | −$0.09 | 55.00% | — | $50,000.00 |

## Frequently Asked Questions

### When did Entera Bio (ENTX) last report earnings?

Entera Bio last reported on Aug 8, 2025, covering fiscal Q2 2025.

### Did ENTX beat earnings estimates?

Yes. Entera Bio reported EPS of −$0.06 for Q2 2025 against a −$0.11 estimate — a 45.45% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).